Daily Stock Ratings & Price Targets

Daily stock ratings from over 8,000 Wall Street analysts

Daily Buy Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Stephen WilleyStifel Nicolaus	GYRE Gyre Therapeutics	BUY$28	267.94% Upside
Naved KhanB.Riley Financial	REAX Real Brokerage	BUY$7	70.73% Upside
Justin PostBank of America Securities	AMZN Amazon	BUY$248	16.56% Upside
Steven LichtmanOppenheimer	DXCM Dexcom	BUY$95	8.48% Upside

Daily Sell Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Kate McShaneGoldman Sachs	RH RH	SELL$179	-2.73% Downside
Julien Dumoulin SmithJefferies	AWK American Water	SELL$117	-17.71% Downside
Bascome MajorsSusquehanna	RXO RXO, Inc.	SELL$12	-25.23% Downside
Manav PatnaikBarclays	FDS Factset Research	SELL$390	-10.88% Downside

Full List of Stock Ratings

(Jun 25, 2025)

Analyst Performance

Any

Analyst Rating

Any

Upside / Downside

Any

Action

Any

Market Cap

Any

Analyst & Firm	Company	Rating & Price Target	Upside / Downside	Average Return	Action	Date	Article
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $175→$185	―	13.70%	Upgraded	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $69	―	27.50%	Initiated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $25	―	26.30%	Upgraded	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $3.5	―	5.30%	Initiated	2025-06-24
William PickeringBernstein	DYN Dyne Therapeutics	HOLD $13	―	-8.60%	Initiated	2025-06-24	Dyne Therapeutics (DYN) Receives a Hold from Bernstein
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $56	―	6.40%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $7	―	4.30%	Initiated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $500	―	6.80%	Initiated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $170	―	6.80%	Initiated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $70	―	6.80%	Initiated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $240	―	11.00%	Reiterated	2025-06-24
Luke SergottBarclays	SRPT Sarepta Therapeutics	BUY $29	―	-9.20%	Reiterated	2025-06-24	Barclays Reaffirms Their Buy Rating on Sarepta Therapeutics (SRPT)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $52	―	10.40%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $235	―	11.60%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $74	―	0.40%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $1,100	―	2.30%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $402→$405	―	12.60%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $53→$52	―	3.50%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $40	―	0.20%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $28	―	0.80%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $402	―	12.60%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $31	―	7.50%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $290	―	13.30%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $390→$393	―	2.10%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $422→$511	―	13.40%	Reiterated	2025-06-24
Bob HuangMorgan Stanley	VOYA Voya Financial	BUY $86→$88	―	-0.10%	Reiterated	2025-06-24	Positive Outlook for Voya Financial Driven by Strategic Growth in Health and Wealth Segments
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $404	―	14.00%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $173	―	14.40%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $200→$262	―	0.70%	Reiterated	2025-06-24
Betty JiangBarclays	EOG EOG Resources	HOLD $140	―	-1.60%	Reiterated	2025-06-24	EOG Resources (EOG) Receives a Hold from Barclays
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $94	―	7.50%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $53→$51	―	5.20%	Reiterated	2025-06-24
Betty JiangBarclays	APA APA	HOLD $19	―	-1.60%	Reiterated	2025-06-24	Barclays Sticks to Their Hold Rating for APA (APA)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $20→$21	―	15.80%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $30	―	10.70%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $300	―	2.40%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $58→$54	―	7.90%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $151	―	9.70%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $405	―	9.70%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $65	―	14.00%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $200	―	4.30%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $10	―	5.60%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $110	―	6.10%	Upgraded	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $229→$228	―	11.60%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $200	―	6.80%	Initiated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $169	―	1.70%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $320	―	6.80%	Initiated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $42	―	2.20%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $78	―	5.80%	Reiterated	2025-06-24
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $146→$170	―	2.80%	Reiterated	2025-06-24

Rows:

Ready for the Full Picture?Your current plan limits your access to top-tier analyst ratings. Subscribe to Premium now and unlock the full range of ratings from the highest-ranked analysts on Wall Street. Don't let partial views limit your market research potential - upgrade today!

Upgrade Now Plans & Pricing